German drugs and pesticides company Bayer was at pains on Thursday to quell expectations it was nearing an out-of-court settlement laying to rest claims its glyphosate-based cause cancer. Bayer said after publishing its earnings outlook for 2020 it was in …
Source: Claims Journal